Tele-health is one of the top ten medical innovations of 2018. Its focus: diagnosing and treating patients remotely using smartphones and Apps. One Israeli company heading to CIIE this November is a tele-health frontrunner looking to market products and build strong partnerships with China. CGTN's Stephanie Freid has this report.

YAAKOV GEVA, CEO G MEDICAL TECHNOLOGIES, TEL AVIV "Think about Beijing. Think about Guangzhou or Shenzhen or any one of those cities, if you wanna go to the hospital you will spend two hours each direction. And you will spend seven hours sitting or queuing to see a doctor for one and a half minute."

Dr. Geva says in China that's just the way it is for now. His aim is to infiltrate the Chinese market with technology that will eventually render doctor's office visits obsolete.

STEPHANIE FREID TEL AVIV "The idea is that by using a few simple products, like this or this that attaches to a cell phone, the diagnostic process for the consumer and the physician is simplified and it becomes remote."

For instance, heart patients who apply this chest patch are monitored by an attending physician via a cellphone. Other devices analyze and transmit urine and blood tests to medical personnel on demand. Med-sector innovation is a pillar of Israel's tech surge - technologies vision restoration to the blind, novel cancer tumor treatment and a robotics system that enables the wheelchair-bound to walk. AI-related startups, including med-tech, raised nearly 2 billion dollars in 201, 600 million of that came from China.

ILAN MAOR ISRAEL-CHINA CHAMBER OF COMMERCE, TEL AVIV "Almost every company you talk with, they're talking about China. And China is becoming a player here. It's going to take time. But China is becoming a player."

YAAKOV GEVA, CEO G MEDICAL TECHNOLOGIES, TEL AVIV "China for us, is no question, the most important today."

China offers Israel sizeable market opportunities and substantial growth potential. G-Medical operates a soon-to-go public venture with China's government of Guangzhou province where products are currently in the clinical trial phase. STEPHANIE FREID, CGTN, TEL AVIV.